Cargando…
Hypercalcemia of Malignancy Attributed to Cosecretion of PTH and PTHRP in Lung Adenocarcinoma
INTRODUCTION: Hypercalcemia of malignancy (HCM) portends a very poor prognosis, and no established guidelines exist regarding its management. Most instances of HCM are due to local osteolysis or secretion of parathyroid hormone related-peptide, while less than 1% of all cases are due to ectopic secr...
Autores principales: | Kroopnick, Jeffrey M., Martinez-Outschoorn, Ubaldo, Tuluc, Madalina, Kim, Caroline S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association of Clinical Endocrinology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165115/ https://www.ncbi.nlm.nih.gov/pubmed/34095488 http://dx.doi.org/10.1016/j.aace.2021.01.003 |
Ejemplares similares
-
SAT-346 Hypercalcemia Secondary to Calcitriol and PTHrP Cosecretion Only Responsive to Hydroxychloroquine
por: Panvelker, Samir S, et al.
Publicado: (2020) -
Substernal oxyphil parathyroid adenoma producing PTHrP with hypercalcemia and normal PTH level
por: Gurrado, Angela, et al.
Publicado: (2008) -
PTHrP and the PTH/PTHrP receptor are co-expressed in human breast and colon tumours.
por: Carron, J. A., et al.
Publicado: (1997) -
SAT-153 PTHrP Mediated Hypercalcemia
por: Arguello, Mingxue
Publicado: (2020) -
Optimization of PTH/PTHrP Hybrid Peptides to Derive a Long‐Acting PTH Analog (LA‐PTH)
por: Noda, Hiroshi, et al.
Publicado: (2020)